Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-21-011312

CEO gave up 173,241 shares (to pay taxes)

  • CEO acquired 75,880 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-30 Shares withheld for taxes : show line 1 in the form −19,984 $41.80 $835,329 614,092 D
2021-03-30 Shares withheld for taxes : show line 2 in the form −8,667 $42.80 $370,906 594,108 D
2021-03-30 Shares withheld for taxes : show line 3 in the form −48,732 $43.86 $2,137,152 545,376 D
2021-03-30 Shares withheld for taxes : show line 4 in the form −8,505 $44.34 $377,105 536,871 D
2021-03-31 Exercise or conversion : show line 5 in the form +75,880 $1.69 $128,237 612,751 D
2021-03-31 Shares withheld for taxes : show line 6 in the form −3,000 $45.59 $136,770 609,751 D
2021-03-31 Shares withheld for taxes : show line 7 in the form −61,350 $44.24 $2,714,320 548,401 D
2021-03-31 Shares withheld for taxes : show line 8 in the form −23,003 $45.06 $1,036,557 525,398 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-03-31 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −75,880 $1.69 2027-04-12 75,880 0 D
Loading xslF345X03/form4.xml…